Abstract
The current study entails the development and validation of a high-performance liquid chromatographic method for quantitative estimation of isotretinoin present in bulk, pharmaceutical dosage forms as well as in human plasma and skin as biological matrix. The method employed reversed phase chromatography employing an RP-C18 column with an isocratic mobile phase consisting of acetonitrile, methanol and water (50:45:5 v/v) set at a flow rate of 0.8 ml/min. The analyte detection was done by ultraviolet detection (UV) at 355 nm. The pH of the mobile phase was adjusted to 4.5 ± 0.01 using acetic acid. The isotretinoin was extracted from plasma by liquid-liquid extraction method. A sharp peak with peak asymmetry value of 1.16 was observed for isotretinoin at a retention time of 5.2 ± 0.01 min. The regression equation was linear over concentration range between 0.1-100 g/ml and regression co-efficient was found to be 0.999 with good accuracy and precision. The limit of detection (LOD) and quantification (LOQ) were found to be 0.006 and 0.018 g/ml, respectively. The wide range of linearity, accuracy, short retention time and isocratic elution imply that the method is suitable for routine estimation of isotretinoin in bulk, pharmaceutical dosage forms and human plasma with good accuracy and precision.
Keywords: Validation, isotretinoin, RP-HPLC, biological matrix, skin, human plasma, pharmaceutical dosage form.
Graphical Abstract
Related Journals
Related Books
New Findings from Natural Substances
Pharmaceutical Chemistry and Production: An Introductory Textbook
Evidence-Based Research in Ayurveda against COVID-19 in Compliance with Standardized Protocols and Practices
Pharmaceuticals for Targeting Coronaviruses
Medical Applications of Beta-Glucan
Nanotechnology Driven Herbal Medicine for Burns: From Concept to Application
Postbiotics: Science, Technology and Applications
Biologically Active Natural Products from Asia and Africa: A Selection of Topics
28
1